Novo Nordisk, maker of Ozempic, applied for FDA approval for a weight loss pill, less than a week after rival Eli Lilly's clinical trial success.

With the growing popularity of weight loss medications, many people are turning to prescription options to help them achieve their health goals. Medications like Ozempic, Mounjaro, and Wegovy are ...

The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

From cayenne pepper to berberine, here are four essential herbs that are great for weight loss and metabolism support.

Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.

Explore the benefits of Mochi Health, a telehealth platform offering personalized weight loss solutions and support.

Novo Nordisk’s Vikrant Shrotriya on accelerating Wegovy’s launch, pricing strategy, and building long-term obesity care ...

Ozempic has already taken the world by storm as a weight loss game-changer, but now, scientists say its impact might go much deeper than the number on the scale. New research suggests that this ...

Saxenda – for weight loss), Dulaglutide (Trulicity), Semaglutide (Ozempic for diabetes, Wegovy for weight loss, Rybelsus oral tablet), Tirzepatide (Mounjaro – a dual GIP/GLP-1 agonist, with even ...

Can ozempic help prevent Alzheimer’s ... Guo added that although some newer GLP-1 drugs are now approved for weight loss, their use for obesity is still relatively recent.

Two new studies published in JAMA Neurology reveal that GLP-1 receptor agonists, like Ozempic and Trulicity, may significantly reduce the risk of dementia, particularly in individuals with type 2 ...